Botanix Pharmaceuticals Limited (BOT.AX)
AUD 0.36
(-4.05%)
AUD 0.36
(-4.05%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -13.91 Million AUD | -52.86% |
| 2023 | -9.1 Million AUD | 19.7% |
| 2022 | -15.74 Million AUD | -55.29% |
| 2021 | -10.06 Million AUD | 57.89% |
| 2020 | -24.14 Million AUD | -10.59% |
| 2019 | -17.15 Million AUD | -68.8% |
| 2018 | -11 Million AUD | -169.25% |
| 2017 | -4.76 Million AUD | -181.41% |
| 2016 | -1.7 Million AUD | -224.43% |
| 2015 | -526.42 Thousand AUD | 57.2% |
| 2014 | -1.22 Million AUD | 32.48% |
| 2013 | -1.82 Million AUD | -22.39% |
| 2012 | -1.48 Million AUD | 1.81% |
| 2011 | -1.51 Million AUD | 23.63% |
| 2010 | -3.94 Million AUD | 37.04% |
| 2009 | -3.14 Million AUD | 0.41% |
| 2008 | -3.13 Million AUD | 14.66% |
| 2007 | -3.65 Million AUD | -16.71% |
| 2006 | -3.06 Million AUD | -113.45% |
| 2005 | -30.21 Million AUD | 3419.5% |
| 2004 | -713.35 Thousand AUD | 27.64% |
| 2003 | -982.6 Thousand AUD | -152.96% |
| 2002 | -389.07 Thousand AUD | 11.99% |
| 2001 | -441.99 Thousand AUD | 87.05% |
| 2000 | -3.41 Million AUD | 56.72% |
| 1999 | -7.88 Million AUD | 51.95% |
| 1998 | -16.41 Million AUD | -14.02% |
| 1997 | -14.39 Million AUD | -378.42% |
| 1996 | 5.17 Million AUD | -48.8% |
| 1995 | 10.1 Million AUD | 39.81% |
| 1994 | 7.22 Million AUD | 132.28% |
| 1993 | 3.11 Million AUD | 413.82% |
| 1992 | -991 Thousand AUD | -139.0% |
| 1991 | 2.54 Million AUD | 215.26% |
| 1990 | 806 Thousand AUD | -55.76% |
| 1989 | 1.82 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -8.4 Million AUD | 0.0% |
| 2024 FY | - AUD | -21.3% |
| 2024 Q2 | -5.51 Million AUD | 0.0% |
| 2023 Q2 | -8.26 Million AUD | 0.0% |
| 2023 FY | - AUD | 19.7% |
| 2023 Q4 | -4.42 Million AUD | 0.0% |
| 2022 Q2 | -6.45 Million AUD | 0.0% |
| 2022 FY | - AUD | -55.29% |
| 2022 Q4 | -9.34 Million AUD | 0.0% |
| 2021 Q4 | -3.95 Million AUD | 0.0% |
| 2021 FY | - AUD | 57.89% |
| 2021 Q2 | -6.22 Million AUD | 0.0% |
| 2020 Q2 | -14.48 Million AUD | 0.0% |
| 2020 Q4 | -9.66 Million AUD | 0.0% |
| 2020 FY | - AUD | -10.59% |
| 2019 Q4 | -17.15 Million AUD | 0.0% |
| 2019 FY | - AUD | -68.8% |
| 2019 Q2 | 72.07 Thousand AUD | 0.0% |
| 2018 FY | - AUD | -169.25% |
| 2018 Q2 | 21.33 Thousand AUD | 0.0% |
| 2018 Q4 | 129.73 Thousand AUD | 0.0% |
| 2017 Q4 | 42.66 Thousand AUD | 0.0% |
| 2017 Q2 | -9609.00 AUD | 0.0% |
| 2017 FY | - AUD | -181.41% |
| 2016 Q1 | -253.37 Thousand AUD | 0.0% |
| 2016 Q2 | -103.00 AUD | 99.96% |
| 2016 Q4 | -1.52 Million AUD | -257.67% |
| 2016 FY | - AUD | -224.43% |
| 2016 Q3 | -426.97 Thousand AUD | -414437.14% |
| 2015 Q2 | -253.37 Thousand AUD | 17.6% |
| 2015 Q3 | -253.37 Thousand AUD | 0.0% |
| 2015 FY | - AUD | 57.2% |
| 2015 Q4 | - AUD | 100.0% |
| 2015 Q1 | -307.49 Thousand AUD | 0.0% |
| 2014 Q2 | -307.49 Thousand AUD | 32.61% |
| 2014 Q3 | -307.49 Thousand AUD | 0.0% |
| 2014 Q1 | -456.27 Thousand AUD | 0.0% |
| 2014 Q4 | - AUD | 100.0% |
| 2014 FY | - AUD | 32.48% |
| 2013 Q1 | -372.1 Thousand AUD | 0.0% |
| 2013 Q3 | -456.27 Thousand AUD | 0.0% |
| 2013 FY | - AUD | -22.39% |
| 2013 Q2 | -456.27 Thousand AUD | -22.62% |
| 2013 Q4 | - AUD | 100.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 Q2 | -372.1 Thousand AUD | 1.8% |
| 2012 Q3 | -372.1 Thousand AUD | 0.0% |
| 2012 Q1 | -378.94 Thousand AUD | 0.0% |
| 2012 FY | - AUD | 1.81% |
| 2011 FY | - AUD | 23.63% |
| 2011 Q3 | -378.94 Thousand AUD | 0.0% |
| 2011 Q2 | -378.94 Thousand AUD | 61.54% |
| 2011 Q1 | -985.25 Thousand AUD | 0.0% |
| 2011 Q4 | - AUD | 100.0% |
| 2010 FY | - AUD | 37.04% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -985.25 Thousand AUD | 0.0% |
| 2010 Q2 | -985.25 Thousand AUD | -25.36% |
| 2010 Q1 | -785.96 Thousand AUD | 0.0% |
| 2009 FY | - AUD | 0.41% |
| 2009 Q1 | -782.8 Thousand AUD | 0.0% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 Q3 | -785.96 Thousand AUD | 0.0% |
| 2009 Q2 | -785.96 Thousand AUD | -0.4% |
| 2008 FY | - AUD | 14.66% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q3 | -782.8 Thousand AUD | 0.0% |
| 2008 Q2 | -782.8 Thousand AUD | 14.42% |
| 2008 Q1 | -914.72 Thousand AUD | 0.0% |
| 2007 Q3 | -914.72 Thousand AUD | 0.0% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 Q2 | -914.72 Thousand AUD | -19.23% |
| 2007 Q1 | -767.19 Thousand AUD | 0.0% |
| 2007 FY | - AUD | -16.71% |
| 2006 FY | - AUD | -113.45% |
| 2006 Q3 | -767.19 Thousand AUD | 0.0% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q2 | -767.19 Thousand AUD | 89.69% |
| 2006 Q1 | -7.44 Million AUD | 0.0% |
| 2005 Q2 | -7.44 Million AUD | -1697.79% |
| 2005 FY | - AUD | 3419.5% |
| 2005 Q1 | -413.88 Thousand AUD | 0.0% |
| 2005 Q4 | - AUD | 100.0% |
| 2005 Q3 | -7.44 Million AUD | 0.0% |
| 2004 Q4 | - AUD | 100.0% |
| 2004 Q2 | -413.88 Thousand AUD | -68.48% |
| 2004 Q1 | -245.65 Thousand AUD | 0.0% |
| 2004 FY | - AUD | 27.64% |
| 2004 Q3 | -413.88 Thousand AUD | 0.0% |
| 2003 FY | - AUD | -152.96% |
| 2003 Q3 | -245.65 Thousand AUD | 0.0% |
| 2003 Q1 | -645.97 Thousand AUD | 0.0% |
| 2003 Q4 | - AUD | 100.0% |
| 2003 Q2 | -245.65 Thousand AUD | 61.97% |
| 2002 Q2 | -645.97 Thousand AUD | -265.98% |
| 2002 Q4 | - AUD | 100.0% |
| 2002 FY | - AUD | 11.99% |
| 2002 Q3 | -645.97 Thousand AUD | 0.0% |
| 2002 Q1 | -176.5 Thousand AUD | 0.0% |
| 2001 Q3 | -176.5 Thousand AUD | 0.0% |
| 2001 Q2 | -176.5 Thousand AUD | 89.28% |
| 2001 Q4 | - AUD | 100.0% |
| 2001 Q1 | -1.64 Million AUD | 0.0% |
| 2001 FY | - AUD | 87.05% |
| 2000 Q2 | -1.64 Million AUD | 17.4% |
| 2000 FY | - AUD | 56.72% |
| 2000 Q4 | - AUD | 100.0% |
| 2000 Q3 | -1.64 Million AUD | 0.0% |
| 2000 Q1 | -1.99 Million AUD | 0.0% |
| 1999 Q1 | -4.08 Million AUD | 0.0% |
| 1999 Q4 | - AUD | 100.0% |
| 1999 FY | - AUD | 51.95% |
| 1999 Q2 | -1.99 Million AUD | 51.18% |
| 1999 Q3 | -1.99 Million AUD | 0.0% |
| 1998 FY | - AUD | -14.02% |
| 1998 Q1 | -887.25 Thousand AUD | 0.0% |
| 1998 Q3 | -4.08 Million AUD | 0.0% |
| 1998 Q2 | -4.08 Million AUD | -360.13% |
| 1998 Q4 | -4.08 Million AUD | 0.0% |
| 1997 Q4 | - AUD | 100.0% |
| 1997 FY | - AUD | -378.42% |
| 1997 Q1 | 10.33 Million AUD | 0.0% |
| 1997 Q2 | -887.25 Thousand AUD | -108.59% |
| 1997 Q3 | -887.25 Thousand AUD | 0.0% |
| 1996 Q2 | 10.33 Million AUD | 136.88% |
| 1996 Q4 | 10.33 Million AUD | 0.0% |
| 1996 FY | - AUD | -48.8% |
| 1996 Q1 | 4.36 Million AUD | 0.0% |
| 1996 Q3 | 10.33 Million AUD | 0.0% |
| 1995 FY | - AUD | 39.81% |
| 1995 Q1 | 3.04 Million AUD | 0.0% |
| 1995 Q4 | 4.36 Million AUD | 0.0% |
| 1995 Q3 | 4.36 Million AUD | 0.0% |
| 1995 Q2 | 4.36 Million AUD | 43.1% |
| 1994 Q2 | 3.04 Million AUD | 66.26% |
| 1994 FY | - AUD | 132.28% |
| 1994 Q4 | 3.04 Million AUD | 0.0% |
| 1994 Q3 | 3.04 Million AUD | 0.0% |
| 1994 Q1 | 1.83 Million AUD | 0.0% |
| 1993 Q1 | 6.72 Million AUD | 0.0% |
| 1993 FY | - AUD | 413.82% |
| 1993 Q4 | 1.83 Million AUD | 0.0% |
| 1993 Q3 | 1.83 Million AUD | 0.0% |
| 1993 Q2 | 1.83 Million AUD | -72.72% |
| 1992 Q2 | 6.72 Million AUD | 386.5% |
| 1992 Q1 | 1.38 Million AUD | 0.0% |
| 1992 Q3 | 6.72 Million AUD | 0.0% |
| 1992 FY | - AUD | -139.0% |
| 1992 Q4 | 6.72 Million AUD | 0.0% |
| 1991 Q4 | 1.38 Million AUD | 0.0% |
| 1991 FY | - AUD | 215.26% |
| 1991 Q1 | 906.5 Thousand AUD | 0.0% |
| 1991 Q2 | 1.38 Million AUD | 52.4% |
| 1991 Q3 | 1.38 Million AUD | 0.0% |
| 1990 Q1 | 1.14 Million AUD | 0.0% |
| 1990 Q2 | 906.5 Thousand AUD | -20.98% |
| 1990 FY | - AUD | -55.76% |
| 1990 Q3 | 906.5 Thousand AUD | 0.0% |
| 1990 Q4 | 906.5 Thousand AUD | 0.0% |
| 1989 Q3 | 1.14 Million AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| 1989 Q4 | 1.14 Million AUD | 0.0% |
| 1989 Q2 | 1.14 Million AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AdAlta Limited | -5.3 Million AUD | -162.496% |
| Acrux Limited | -7.93 Million AUD | -75.506% |
| Actinogen Medical Limited | -12.92 Million AUD | -7.725% |
| AnteoTech Limited | -11.57 Million AUD | -20.296% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -633.529% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -57.581% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -855.565% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 28.88% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -205.276% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -329.278% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -367.88% |
| Biome Australia Limited | -1.57 Million AUD | -781.949% |
| Biotron Limited | -5.04 Million AUD | -176.175% |
| BTC Health Limited | 1.05 Million AUD | 1419.013% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -23.183% |
| CSL Limited | 4.73 Billion AUD | 100.294% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 68.824% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 126.839% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -39.89% |
| Dimerix Limited | -24.95 Million AUD | 44.23% |
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 234.157% |
| Hexima Limited | -995.54 Thousand AUD | -1298.169% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -393.925% |
| Immuron Limited | -6.19 Million AUD | -124.783% |
| Immutep Limited | -42.87 Million AUD | 67.535% |
| Imugene Limited | -147.97 Million AUD | 90.594% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -1832.063% |
| Memphasys Limited | -3.3 Million AUD | -320.815% |
| Nanollose Limited | -1.14 Million AUD | -1112.593% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 106.985% |
| Noxopharm Limited | -5.94 Million AUD | -134.116% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -674.898% |
| Nyrada Inc. | -4.59 Million AUD | -202.845% |
| Orthocell Limited | -11.68 Million AUD | -19.161% |
| PharmAust Limited | -9.45 Million AUD | -47.268% |
| Patrys Limited | -3.49 Million AUD | -298.59% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 78.433% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -76.478% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -93.709% |
| PYC Therapeutics Limited | -38.11 Million AUD | 63.483% |
| Race Oncology Limited | -14.2 Million AUD | 2.0% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 69.324% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 34.816% |
| Starpharma Holdings Limited | -12.57 Million AUD | -10.673% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 160.609% |
| Tissue Repair Ltd | -5.77 Million AUD | -141.028% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 61.803% |